SCHEDULE: Olesen Fund Trims Solitron Stake to 11.5%

Sentiment:

Schedule 13D Amendment


Olesen Value Fund L.P. has reduced its beneficial ownership in Solitron Devices Inc. to 11.5% while maintaining an investment purpose and seeking shareholder value discussions.

Worse than expectedThe Reporting Persons sold 17,021 shares of Solitron Devices Inc. common stock in August 2025.This reduction in stake, from a significant shareholder, could be interpreted as a decrease in conviction or a move to reallocate capital.

Summary

  • Olesen Value Fund L.P., Olesen Value Fund GP LLC, and Christian Olesen (Reporting Persons) beneficially own 239,487 shares of Solitron Devices Inc. common stock.
  • This represents approximately 11.5% of the Issuer's 2,082,553 outstanding shares as of July 11, 2025.
  • The shares were acquired in open market transactions using general working capital for an aggregate purchase price of approximately $897,584.
  • The investment is for investment purposes, and the Reporting Persons are interested in discussing options for shareholder value creation with Solitron's management, board, or third parties.
  • The Reporting Persons may adjust their investment (hold, increase, or decrease) based on market conditions and Solitron's financial performance.
  • During the last 60 days, Olesen Value Fund L.P. sold a total of 17,021 shares of Solitron Devices Inc. common stock across five transactions between August 8, 2025, and August 18, 2025, at prices ranging from $16.10 to $16.50 per share.

Sentiment

Score: 4

Explanation: The filing indicates a reduction in the investor's stake through recent sales, which can be viewed negatively. However, the investor still holds a substantial 11.5% position and explicitly states an interest in discussing shareholder value creation, suggesting potential future engagement that could be beneficial.

Positives

  • Reporting Persons are interested in discussing options for shareholder value creation, indicating potential future engagement to enhance company performance.
  • The fund maintains a significant 11.5% stake, suggesting continued belief in the company's long-term potential despite recent sales.

Negatives

  • Olesen Value Fund L.P. sold 17,021 shares in August 2025, which could signal a reduction in conviction or a rebalancing of their portfolio.
  • The sales occurred at prices between $16.10 and $16.50, which might indicate a ceiling or profit-taking at those levels.

Risks

  • The Reporting Persons may decrease their investment in the Common Stock, which could put downward pressure on the share price.
  • The shares are held in margin accounts, which may from time to time have debit balances, potentially exposing the fund to margin calls or forced sales under adverse market conditions.

Future Outlook

The Reporting Persons intend to hold their investment for investment purposes and are open to discussing shareholder value creation with Solitron Devices Inc.'s management and board. They may adjust their position (hold, increase, or decrease) based on ongoing evaluations of market conditions and the Issuer's financial performance.

Industry Context

This filing reflects an institutional investor's ongoing management of a significant stake in a publicly traded company. While specific industry trends are not detailed, the stated intent to discuss 'shareholder value creation' is a common theme among activist or engaged investors seeking to influence corporate strategy or governance.

Stakeholder Impact

  • Shareholders: The reduction in stake by a significant investor could lead to negative sentiment or downward pressure on the stock price. Conversely, the stated intent to discuss shareholder value creation could be seen as a positive for long-term shareholders if it leads to beneficial strategic changes.

Next Steps

  • Reporting Persons may engage in discussions with Solitron Devices Inc.'s management, board of directors, and/or third parties regarding options for shareholder value creation.
  • Reporting Persons may determine whether to hold, increase, or decrease their investment in Solitron Devices Inc. common stock based on ongoing evaluations.

Key Dates

DateDescription
2025-07-11Date of Form 10-Q filing used to compute outstanding shares (2,082,553 shares).
2025-08-08Olesen Value Fund L.P. sold 1,500 shares at $16.50/share.
2025-08-11Olesen Value Fund L.P. sold 2,720 shares at $16.21/share.
2025-08-14Olesen Value Fund L.P. sold 1,500 shares at $16.10/share.
2025-08-15Olesen Value Fund L.P. sold 4,000 shares at $16.19/share.
2025-08-18Date of event requiring filing of this statement; Olesen Value Fund L.P. sold 7,301 shares at $16.34/share.
2025-08-19Date of filing of this statement.

Recommendation

hold

While the recent share sales by Olesen Value Fund L.P. introduce a degree of uncertainty and potential negative sentiment, the fund retains a substantial 11.5% stake and explicitly states an interest in engaging with Solitron Devices Inc. management to discuss shareholder value creation. This suggests a potential for future positive developments through active investor engagement. Investors should hold to observe the outcome of these potential discussions and the company's future performance.

Keywords

Solitron Devices Inc., SDR, Olesen Value Fund, Schedule 13D, Shareholder Activism, Investment Fund, Common Stock, Share Ownership, SEC Filing, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.